type columns. 1,2,4-Trichlorobenzene (TCB) was employed as the
solvent at a flow rate of 1.0 mL min-1. The calibration was made
by polystyrene standard EasiCal PS-1 (PL Ltd).
Calc. for C37H26Cl2F8N2O2Ti: C 55.45, H 3.27, N 3.50. Found: C
55.41, H 3.30, N 3.45.
[3-But-2-OC6H3CH N(C6F5)][PhN C(CF3)CHC(p-PhPh)O]-
TiCl2 (3c). Catalyst 3c was prepared via a procedure similar to
that for 3a as dark red needles in 63% yield. 1H NMR (300 MHZ,
CDCl3, 20 ◦C): d 8.41 (s, 1H, CH N), 8.25 (s, 1H, Ar) 7.89–7.97
(d, 1H, Ar), 7.82–7.86 (d, 2H, Ar), 7.75–7.79 (d, 1H, Ar),
7.56–7.61 (q, 5H, Ar), 7.13–7.18 (m, 3H, Ar), 6.98–7.03 (t, 1H,
Ar), 6.88–6.91(t, 1H, Ar), 6.75–6.81 (t, 1H, Ar), 6.69 (s,1H, CH),
6.59–6.62 (d, 1H, Ar), 1.30 (s, 9H, t-Bu). 13C NMR (75.5 MHZ,
TiCl4 and Me3SiCl were purchased from Aldrich. KH (40% min-
eral oil suspension) was purchased from Aldrich and washed with
light petroleum. Modified methylaluminoxane (MMAO, 7% alu-
minium in heptane solution), R3Al, B(C6F5)3 and Ph3CB(C6F5)4
were purchased from Akzo Nobel Chemical Inc. Norbornene
was purchased from Aldrich and purified by sublimation under
reduced pressure before use. The stock solution of NB was
prepared in toluene (6.07 M). The other reagents and solvents
were commercially available.
◦
CDCl3, 20 C): d 176.6, 172.6, 160.8, 157.5, 147.3, 139.7, 138.9,
136.5, 134.0, 132.1, 129.0, 128.4, 128.3, 128.1, 127.6, 127.2, 127.1,
126.5, 126.3, 125.4, 123.1, 122.3, 121.1, 117.3, 96.0, 35.2, 30.0.
Anal. Calc. for C39H28Cl2F8N2O2Ti: C 56.61, H 3.41, N 3.39.
Found: C 56.59, H 3.39, N 3.35.
Synthesis of titanium catalysts
[3-But-2-OC6H3CH N(C6F5)][PhN C(CF3)CHC(Ph)O]TiCl2
(3a). To a solution of compound 3-But-2-OC6H3CH N(C6F5)
(0.69 g, 2 mmol) in dried tetrahydrofuran (20 mL) at -78 ◦C
was added a 2.5 M n-butyllithium hexane solution (0.8 mL,
2 mmol) dropwise over 5 min. The mixture was allowed to warm
to room temperature and stirred for 4 h, affording a yellow
[3-But-2-OC6H3CH N(C6F5)][PhN C(CF3)CHC(o-PhPh)O]-
TiCl2 (3d). Catalyst 3d was prepared via a procedure similar to
that for 3a as dark red needles in 58% yield. 1H NMR (300 MHZ,
CDCl3, 20 ◦C): d 8.13 (s, 1H, CH N), 7.77–7.79 (d, 1H,
Ar),7.47–7.55 (q, 2H, Ar), 7.25–7.48 (m, 6H, Ar), 7.14–7.18 (t,
2H, Ar), 7.08–7.11(q, 1H, Ar), 6.91–6.99 (m, 2H, Ar), 6.70–6.80
(m, 2H, Ar), 6.56–6.58 (d, 1H, Ar), 5.79 (s, 1H, CH), 1.39 (s,
◦
solution. Then, at 0 C (CH3)3SiCl (4 mmol, 0.5 mL) was added
dropwise over 3 min and stirred for 18 h, the formed colorless
solution was concentrated and added dried toluene 15 mL, then
filtered. The colorless filtrate was added dropwise to a toluene
solution of TiCl4 (2 mmol) at 0 ◦C, and allowed to warm to
room temperature, then evaporated under reduced pressure after
stirred for 12 h to afford a solid residue, which was needed to
recrystallized with dichloromethane and hexane to form dark red
solid [3-But-2-OC6H3CH N(C6F5)]TiCl3(THF). Thereupon, a
solution of [3-Bu-2-OC6H3CH N (C6F5)]TiCl3(THF) (0.78 g,
1.4 mmol) in dichlorometane (10 mL) at -78 ◦C was treated with
[PhN C(CF3)CHC(Ph)]OK (0.46 g, 1.4 mmol). The reaction
mixtures was allowed to warm slowly to room temperature and
stirred for 20 h, affording a dark red solution. The solution was
filtered to remove KCl and the isolated product was concentrated.
Purification by precipitation from dichloromethane/hexane at
room temperature gives the desired complex a dark red power in
◦
9H, t-Bu).13C NMR (75.5 MHZ, CDCl3, 20 C): d 176.6, 172.6,
160.8, 158.5, 148.3, 139.9, 138.4, 136.2, 134.3, 132.0, 129.2, 128.3,
128.2, 128.1, 127.6, 127.2, 127.1, 126.5, 126.3, 125.4, 123.1, 122.3,
121.1, 117.3, 96.0, 35.2, 30.0. Anal. Calc. for C39H28Cl2F8N2O2Ti:
C 56.61, H 3.41, N 3.39. Found: C 56.55, H 3.37, N 3.36.
[3-But -2-OC6H3CH N(C6F5)][PhN C(CF3)CHC(2,6-F2Ph)-
O]TiCl2 (3e). Catalyst 3e was prepared via a procedure similar
to that for 3a as dark red needles in 68% yield. 1H NMR (CDCl3,
◦
20 C): d 8.18 (s, 1H, CH N), 7.53–7.58 (t, 1H, Ar), 7.30–7.44
(m, 1H, Ar), 7.13–7.16 (d, 2H, Ar), 7.00–7.07 (t, 1H, Ar), 6.95–
6.99 (m, 3H, Ar), 6.76–6.89 (m, 2H, Ar), 6.64–6.67 (d, 1H, Ar),
6.36 (s,1H, CH), 1.35 (s, 9H, t-Bu).13C NMR (75.5 MHZ, CDCl3,
20 ◦C): d 161.3, 155.0, 147.1, 139.0, 137.2, 135.9, 134.6, 133.9,
132.7, 131.3, 128.9, 127.6, 127.0, 126.5, 123.8, 122.3, 102.2, 77.9,
77.4, 76.9, 35.6, 30.4. Anal. Calc. for C33H22F2Cl2F8N2O2Ti: C
50.34, H 2.82, N 3.56. Found: C 50.36, H 2.84, N 3.52.
55% yield. H NMR (300 MHZ, CDCl3, 20 ◦C): d 8.24 (s, 1H,
1
CH N), 7.83–7.86 (q, 2H, Ar), 7.54–7.59 (m, 2H, Ar), 7.43–7.48
(t, 2H, Ar), 7.23 (t,1H, Ar), 7.10–7.16 (t, 2H, Ar), 6.99–7.04 (t,
1H, Ar), 6.87–6.92 (t, 1H, Ar), 6.74–6.78 (t, 2H, Ar), 6.62–6.64 (t,
1H, Ar), 6.57 (s, 1H, CH), 1.24 (s, 9H, t-Bu). 13C NMR (20 ◦C): d
177.3, 172.9, 147.6, 139.4, 136.8, 134.4, 133.7, 129.4, 128.7, 127.9,
126.9, 126.6, 125.8, 123.5, 122.7, 96.3, 35.6, 30.4. Anal. Calc. for
C33H24Cl2F8N2O2Ti: C 52.75, H 3.22, N 3.73. Found: C 52.71, H
3.27, N 3.68.
[3-But-2-OC6H3CH N(C6F5)][PhN C(CF3)CHC(2,5-Cl2Ph)-
O]TiCl2 (3f). Catalyst 3f was prepared via a procedure similar
to that for 3a as dark red needles in 55% yield. 1H NMR (CDCl3,
20 ◦C): d 8.19 (s, 1H, CH N), 7.63 (s,1H, Ar), 7.54–7.57 (d, 1H,
Ar), 7.35–7.36 (q, 2H, Ar), 7.15–7.17 (d, 2H, Ar), 6.96–7.07 (m,
2H, Ar), 6.77–6.88 (m, 2H, Ar), 6.73 (s, 1H, Ar), 6.63–6.65 (d,
1H, Ar), 1.36 (s, 9H, t-Bu). 13C NMR (75.5 MHZ, CDCl3, 20 ◦C):
d 161.0, 154.9, 146.9, 139.1, 137.0, 135.8, 134.5, 133.8, 132.5,
131.2, 128.9, 127.5, 126.9, 126.4, 123.6, 122.1, 102.1, 77.8, 77.4,
76.9, 35.6, 30.4. Anal. Calc. for C33H22Cl4F8N2O2Ti: C 48.32, H
2.70, N 3.42. Found: C 48.34, H 2.65, N 3.40.
[3-But -2-OC6H3CH N(C6F5)][PhN C(CF3)CHC(1-C10H7)-
O]TiCl2 (3b). Catalyst 3b was prepared via a procedure similar to
that for 3a as a dark red power in 65% yield. 1H NMR (300 MHZ,
CDCl3, 20 ◦C): d 8.28 (s, 1H, CH N), 7.92–7.95 (d, 2H, Ar),
7.68–7.71 (m, 4H, Ar), 7.65–7.67 (d, 1H, Ar), 7.56–7.58 (t, 2H,
Ar), 7.48–7.50 (t, 1H, Ar), 7.15–7.20 (t, 1H, Ar), 6.92–7.01 (t, 1H,
Ar), 6.89–6.91 (t, 1H, Ar), 6.70–6.75 (t, 1H, Ar), 6.60–6.65 (d, 1H,
Ar), 6.59 (s◦, 1H, CH), 1.30 (s, 9H, t-Bu). 13C NMR (75.5 MHZ,
CDCl3, 20 C): d 177.0, 172.5, 160.9, 139.0, 136.5, 135.5, 133.9,
132.8, 130.7, 129.7, 129.4, 129.0, 128.9, 128.8, 128.3, 128.2, 127.8,
127.0, 126.5, 126.3, 125.4, 123.0, 122.8, 96.5, 53.4, 35.2, 30.0. Anal.
[3-But -2-OC6H3CH N(C6F5)][PhN C(CF3)CHC(2,3,4,6-
F4,4-OMePh)O]TiCl2 (3g). Catalyst 3g was prepared via a
procedure similar to that for 3a as dark red needles in 72% yield. 1H
NMR (CDCl3, 20 ◦C): d 8.11 (s, 1H, CH N), 7.48–7.51 (d, 1H,
Ar), 7.16–7.19 (d, 1H, Ar), 7.07–7.10 (d, 1H, Ar), 6.90–7.01 (m,
2H, Ar), 6.75–6.82 (m, 2H, Ar), 6.58–6.60 (d, 1H, Ar), 6.27 (s, 1H,
CH), 4.10 (s, 3H, OMe), 1.32 (s, 9H, t-Bu).13C NMR (75.5 MHZ,
1616 | Dalton Trans., 2011, 40, 1610–1618
This journal is
The Royal Society of Chemistry 2011
©